trending Market Intelligence /marketintelligence/en/news-insights/trending/ZiX4NVSuOKr7vw9nmbKdVQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Mérieux Equity invests in French pharmaceutical laboratory Addmedica

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Mérieux Equity invests in French pharmaceutical laboratory Addmedica

Mérieux Equity Partners SAS made an investment in French pharmaceutical laboratory Addmedica SAS through its Mérieux Participations 3 SLP fund.

The private equity firm became the reference shareholder of the company in partnership with founders François Anger and Bernard Dauvergne.

Addmedica develops and markets medicinal products and medical devices for rare diseases, including a benchmark treatment for inherited blood disorder sickle cell disease. The company will use the capital to expand its global footprint and product portfolio.

Duteil et Associés Law Firm and Advance Capital provided support to Mérieux Equity.